Detalhe da pesquisa
1.
New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.
Malar J
; 16(1): 263, 2017 07 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28673287
2.
Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates.
Malar J
; 10: 65, 2011 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-21410955
3.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
PLoS One
; 16(9): e0256980, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34495988
4.
Molecular vaccines for malaria.
Hum Vaccin
; 6(1): 54-77, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20061792
5.
Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge.
PLoS One
; 15(5): e0232234, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32407410
6.
Development of replication-deficient adenovirus malaria vaccines.
Expert Rev Vaccines
; 16(3): 261-271, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27606709
7.
A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge.
Clin Vaccine Immunol
; 24(4)2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28179404
8.
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.
Vaccine
; 35(31): 3865-3874, 2017 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28596090
9.
Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
PLoS One
; 11(10): e0163026, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27695088
10.
Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
PLoS One
; 11(12): e0168952, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27997615
11.
Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming.
Hum Vaccin Immunother
; 11(11): 2705-15, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26292027
12.
Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
PLoS One
; 10(8): e0136109, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26292257
13.
Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.
PLoS One
; 9(9): e106241, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25211344
14.
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.
Hum Vaccin Immunother
; 9(10): 2165-77, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23899517
15.
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
PLoS One
; 8(2): e55571, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23457473
16.
Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
PLoS One
; 7(4): e33920, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22496772
17.
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
Hum Vaccin Immunother
; 8(11): 1564-84, 2012 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23151451
18.
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults.
PLoS One
; 6(10): e24586, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22003383
19.
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.
PLoS One
; 6(10): e25868, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22003411
20.
Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth.
Vaccine
; 28(18): 3201-10, 2010 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-20188680